These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Minimally invasive biomarkers for detection and staging of colorectal cancer. Booth RA Cancer Lett; 2007 Apr; 249(1):87-96. PubMed ID: 17275174 [TBL] [Abstract][Full Text] [Related]
3. Prognostic and predictive factors in colorectal cancer. Zlobec I; Lugli A J Clin Pathol; 2008 May; 61(5):561-9. PubMed ID: 18326017 [TBL] [Abstract][Full Text] [Related]
4. Clinical implications of genetic variations in the VEGF system in relation to colorectal cancer. Hansen TF; Jakobsen A Pharmacogenomics; 2011 Dec; 12(12):1681-93. PubMed ID: 22118052 [TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience. Ivanov K; Kolev N; Tonev A; Nikolova G; Krasnaliev I; Softova E; Tonchev A Hepatogastroenterology; 2009; 56(89):94-8. PubMed ID: 19453036 [TBL] [Abstract][Full Text] [Related]
10. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance. Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410 [TBL] [Abstract][Full Text] [Related]
12. Methylation status of genes in non-neoplastic mucosa from patients with ulcerative colitis-associated colorectal cancer. Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC Am J Gastroenterol; 2010 Jul; 105(7):1610-9. PubMed ID: 20160714 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA in colorectal cancer: new perspectives for diagnosis, prognosis and treatment. Bonfrate L; Altomare DF; Di Lena M; Travaglio E; Rotelli MT; De Luca A; Portincasa P J Gastrointestin Liver Dis; 2013 Sep; 22(3):311-20. PubMed ID: 24078989 [TBL] [Abstract][Full Text] [Related]
14. The high expression of Fractalkine results in a better prognosis for colorectal cancer patients. Ohta M; Tanaka F; Yamaguchi H; Sadanaga N; Inoue H; Mori M Int J Oncol; 2005 Jan; 26(1):41-7. PubMed ID: 15586223 [TBL] [Abstract][Full Text] [Related]
15. [Omics docking and molecular classification in colorectal cancer]. Peng Y; Shen S Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Nov; 35(11):1201-6. PubMed ID: 21131745 [TBL] [Abstract][Full Text] [Related]
16. Aberrant methylation of genes in stool samples as diagnostic biomarkers for colorectal cancer or adenomas: a meta-analysis. Luo YX; Chen DK; Song SX; Wang L; Wang JP Int J Clin Pract; 2011 Dec; 65(12):1313-20. PubMed ID: 22093539 [TBL] [Abstract][Full Text] [Related]
18. Methylation of helicase-like transcription factor in serum of patients with colorectal cancer is an independent predictor of disease recurrence. Herbst A; Wallner M; Rahmig K; Stieber P; Crispin A; Lamerz R; Kolligs FT Eur J Gastroenterol Hepatol; 2009 May; 21(5):565-9. PubMed ID: 19282772 [TBL] [Abstract][Full Text] [Related]
19. Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue. Li M; Yuan YH; Han Y; Liu YX; Yan L; Wang Y; Gu J Clin Cancer Res; 2005 Mar; 11(5):1809-14. PubMed ID: 15756003 [TBL] [Abstract][Full Text] [Related]
20. Overview of biomarkers in metastatic colorectal cancer: tumour, blood and patient-related factors. Clarke SJ; Karapetis CS; Gibbs P; Pavlakis N; Desai J; Michael M; Tebbutt NC; Price TJ; Tabernero J Crit Rev Oncol Hematol; 2013 Feb; 85(2):121-35. PubMed ID: 22762963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]